Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis.
Mandó P, Fabiano V, Gomez Guasch S, Colucci G, Sánchez-Bayona R, Coló F, Loza M, Von Stecher F, Amat M, de la Vega M, Costanzo MV, Nervo A, Nadal J, Chacón R, Perazzo F; RCM Database Contributors. Mandó P, et al. Among authors: amat m. JCO Glob Oncol. 2024 Nov;10:e2400123. doi: 10.1200/GO.24.00123. Epub 2024 Nov 27. JCO Glob Oncol. 2024. PMID: 39602672
Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database.
Fabiano V, Mandó P, Rizzo M, Ponce C, Coló F, Loza M, Loza J, Amat M, Mysler D, Costanzo MV, Nervo A, Nadal J, Perazzo F, Chacón R; RCM Database Contributors4. Fabiano V, et al. Among authors: amat m. JCO Glob Oncol. 2020 Apr;6:639-646. doi: 10.1200/JGO.19.00228. JCO Glob Oncol. 2020. PMID: 32315233 Free PMC article.
Cyclin-Dependent Kinase 4/6 Inhibitor Outcomes in Patients With Advanced Breast Cancer Carrying Germline Pathogenic Variants in DNA Repair-Related Genes.
Bruno L, Ostinelli A, Waisberg F, Enrico D, Ponce C, Rivero S, Blanco A, Zarba M, Loza M, Fabiano V, Amat M, Pombo MT, Noro L, Chacón M, Coló F, Chacón R, Nadal J, Nervo A, Costanzo V. Bruno L, et al. Among authors: amat m. JCO Precis Oncol. 2022 Mar;6:e2100140. doi: 10.1200/PO.21.00140. JCO Precis Oncol. 2022. PMID: 35235412
High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast Cancers.
Mandó P, Rizzo M, de la Puente CP, Maino M, Ponce C, Pombo MT, Amat M, Costanzo MV, Nervo A, Nadal J, Fabiano V, Loza J, Loza CM, Colo F, Reinaldo C. Mandó P, et al. Among authors: amat m. J Breast Cancer. 2017 Jun;20(2):170-175. doi: 10.4048/jbc.2017.20.2.170. Epub 2017 Jun 26. J Breast Cancer. 2017. PMID: 28690653 Free PMC article.
In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab.
Pesce Viglietti AI, Bordignon MB, Ostinelli A, Rizzo MM, Cueto G, Sanchez MB, Perazzo F, Amat M, Coló F, Costanzo MV, Nervo A, Nadal J, Crimi G, Mc Lean I, Spengler EA, Mordoh J, Mandó P, Levy EM. Pesce Viglietti AI, et al. Among authors: amat m. Int J Mol Sci. 2024 Aug 27;25(17):9268. doi: 10.3390/ijms25179268. Int J Mol Sci. 2024. PMID: 39273217 Free PMC article.
The role of modern parameters and their relationship with recurrence risk as assessed by Oncotype DX: real-world evidence.
Narvaez D, Nadal J, Nervo A, Costanzo V, Paletta C, Petracci F, Rivero S, Ostinelli A, Coló F, Martín L, Fabiano V, Sabatini L, Perazzolo A, Amat M, Chacon M, Waisberg F. Narvaez D, et al. Among authors: amat m. Ecancermedicalscience. 2024 Feb 6;18:1664. doi: 10.3332/ecancer.2024.1664. eCollection 2024. Ecancermedicalscience. 2024. PMID: 38439804 Free PMC article.
The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review.
Narvaez D, Nadal J, Nervo A, Costanzo MV, Paletta C, Petracci FE, Rivero S, Ostinelli A, Freile B, Enrico D, Pombo MT, Amat M, Aguirre ED, Chacon M, Waisberg F. Narvaez D, et al. Among authors: amat m. Cancers (Basel). 2024 Jan 17;16(2):396. doi: 10.3390/cancers16020396. Cancers (Basel). 2024. PMID: 38254885 Free PMC article. Review.
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients.
Roberti MP, Rocca YS, Amat M, Pampena MB, Loza J, Coló F, Fabiano V, Loza CM, Arriaga JM, Bianchini M, Barrio MM, Bravo AI, Domenichini E, Chacón R, Mordoh J, Levy EM. Roberti MP, et al. Among authors: amat m. Breast Cancer Res Treat. 2012 Dec;136(3):659-71. doi: 10.1007/s10549-012-2287-y. Epub 2012 Oct 14. Breast Cancer Res Treat. 2012. PMID: 23065032
Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.
Roberti MP, Juliá EP, Rocca YS, Amat M, Bravo AI, Loza J, Coló F, Loza CM, Fabiano V, Maino M, Podhorzer A, Fainboim L, Barrio MM, Mordoh J, Levy EM. Roberti MP, et al. Among authors: amat m. Eur J Immunol. 2015 May;45(5):1560-9. doi: 10.1002/eji.201445353. Epub 2015 Apr 7. Eur J Immunol. 2015. PMID: 25726929 Free article.
169 results